ONC FY 2018 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

FY 2018 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$198M-16.8% YoY

Gross Profit

-$509M-257.0% margin

Operating Income

-$706M-356.1% margin

Net Income

-$674M-339.9% margin

EPS (Diluted)

$-12.09

Cash Flow

Operating Cash Flow

-$548M

Free Cash Flow

-$689M

Stock-Based Comp.

$87M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$496M

Stockholders' Equity

$1.8B

Cash & Equivalents

$713M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$198M	$238M	-16.8%
Gross Profit	-$509M	-$36M	-1331.0%
Operating Income	-$706M	-$98M	-616.8%
Net Income	-$674M	-$93M	-623.7%